The fundamental agent of angiogenesis, bFGF, promotes the proliferation and the migration of prostatic cancer cells by activation of MAPKs pathway and this effect of bFGF shows to be modulated by SOCS-3 (Suppressor of cytokine signalling-3)[28,45]. This evidence concerns the gene FGF2 and Familial prostate cancer.